Home＞ORGANIZATION
NPO Asks MHLW to Take Steps to Ensure Proper Use of Xeplion(Jun.23.2016)
The nonprofit organization Community Mental Health & Welfare Bonding Organization (COMHBO) submitted a request to the Ministry of Health, Labor and Welfare (MHLW) on June 21 regarding the proper use of the antipsychotic agent Xeplion Aqueous Suspension for IM Injection ...
(LOG IN FOR FULL STORY)
-
- Japan Wholesaler Chief Suzuki Becomes IFPW Chairman Oct.16
-
Asian Consortium for Natural Substance-Based Drug Discovery to Leverage Asian Natural Resources, Japanese Technologies
Oct.15
- Japan Drug Industry Vows Further Efforts in Academic Collaboration after Honjo’s Nobel Prize Oct.03
- Generic Use Rate at 72.2% in April-June: JGA Oct.01
-
October 2019 “Only Option” for Drug Price Revision Tied to Sales Tax Hike: New FPMAJ Chief
Sep.25
- JAK Inhibitor Battle for Atopic Dermatitis Intensifying, 1st Japan Filing Might Be Near(Oct.17)
- MHLW Lifts Contraindications for Combined Statin-Fibrate Use in Renal-Impaired Patients(Oct.17)
- Eisai Seals Latin America Pact for Belviq(Oct.17)
- Teva Takeda Launches Voluntary Recall for Taxotere Generics(Oct.17)
- ADR Victim Relief Claims Fall below 1,500 in FY2017: MHLW(Oct.17)
